The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2022

Filed:

May. 25, 2017
Applicant:

Gencurix Inc., Seoul, KR;

Inventors:

Young Kee Shin, Seoul, KR;

Bohyun Byun, Seoul, KR;

Hyunjeung Choi, Seoul, KR;

Joon Seok Choi, Seoul, KR;

Young Ho Moon, Seoul, KR;

Jong Heun Lee, Seoul, KR;

Sang Rea Cho, Seoul, KR;

Jee Eun Kim, Seoul, KR;

Myungsun Kim, Seoul, KR;

Assignee:

GENCURIX INC, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C07H 21/04 (2006.01); C12Q 1/6827 (2018.01); C12Q 1/6823 (2018.01); C12Q 1/686 (2018.01); C12Q 1/6874 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6827 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6823 (2013.01); C12Q 1/6874 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/16 (2013.01);
Abstract

The present invention relates to a composition for detecting an epidermal cell growth factor receptor gene mutation and to a kit comprising the composition and, more specifically, to a primer and probe set composition for detecting an epidermal cell growth factor gene mutation, and to a kit for detecting an EGFR gene mutation, comprising the composition. A method according to the present invention can not only predict and diagnose responsiveness to a therapeutic agent for the prognosis of a cancer patient, but also predict a cancer metastasis or relapse Thus, the method can be useful for the purposes of determining the need to administer an anticancer therapeutic agent and guiding the direction of future treatment, and for monitoring a cancer metastasis or relapse.


Find Patent Forward Citations

Loading…